Evotec SE (LON:0IRF)
8.57
+0.06 (0.69%)
At close: Feb 20, 2025
Evotec SE Employees
Evotec SE had 5,061 employees as of December 31, 2023. The number of employees increased by 109 or 2.20% compared to the previous year.
Employees
5,061
Change (1Y)
109
Growth (1Y)
2.20%
Revenue / Employee
129.14K GBP
Profits / Employee
-28.48K GBP
Market Cap
1.25B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
Shell | 103,000 |
HSBC Holdings | 220,861 |
Unilever | 128,377 |
Rio Tinto Group | 57,000 |
RELX PLC | 36,400 |
BP p.l.c. | 87,800 |
British American Tobacco p.l.c. | 48,989 |
Evotec SE News
- 4 weeks ago - Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases - Accesswire
- 4 weeks ago - Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases - Accesswire
- 7 weeks ago - Halozyme: Recent Approvals Alter My Appetite - Seeking Alpha
- 7 weeks ago - Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha
- 2 months ago - Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk - Accesswire
- 3 months ago - Evotec Announces Change in Management Board - Accesswire
- 3 months ago - Comment on Withdrawn Non-Binding Offer - Accesswire
- 3 months ago - Halozyme withdraws $2.1 bln buyout offer for Evotec - Reuters